基于基因的重新设计与高通量筛选策略选育解脂耶氏酵母脂肪酶高产菌株

脂肪酶（EC 3.1.1.3）是应用广泛的工业用酶。高效的脂肪酶产生菌是脂肪酶工业生产和应用的前提。通过基因的重新设计与合成技术优化了解脂耶氏酵母（Yarrowia lipolytica）脂肪酶YLL的密码子,并实现了其在毕赤酵母（Pichia pastoris）中的高效表达;通过高通量筛选策略获得了更高效的脂肪酶基因工程菌菌株SILVER。在14 L发酵罐条件下,菌株SILVER酶活达40 500 U/ml、蛋白质含量达2.52 g/L发酵液,为该类脂肪酶的产业化奠定了基础。     

HES4抑制急性T淋巴细胞白血病细胞系Jurkat对阿糖胞苷的敏感性

摘要 目的：研究hes家族bHLH转录因子4（HES4）与急性T淋巴细胞白血病（T-ALL）细胞系Jurkat对化疗药物阿糖胞苷（Ara-C）的敏感性作用。方法：构建Lenti-pCDH-HES4-puro质粒,包装慢病毒感染Jurkat细胞,感染空载体Lenti-pCDH-puro为对照组,puromycin筛选阳性细胞,Realtime-PCR检测转录水平HES4过表达情况,CCK8法检测Jurkat对Ara-C敏感性,Ara-C终浓度为0.1、1、10、100、1000、10000 nmol?L^-1;设计3对针对于HES4的特异sgRNA序列,构建LentiGuide-sgRNA1-puro、LentiGuide-sgRNA2-Puro、LentiGuide-sgRNA3-puro质粒,LentiGuide-puro空载体为对照组,包装慢病毒感染Jurkat细胞,puromycin筛选,提取基因组DNA,PCR扩增sgRNA的靶序列,一代测序检测HES4的敲除效率,CCK8法检测敲除HES4后Jurkat对Ara-C敏感性,Ara-C终浓度为0.1、1、10、100、1000、10000 nmol?L^-1。结果：与对照组相比,HES4在Jurkat中过表达（2.37 ± 0.09）倍（P < 0.001）,在Ara-C为1 nmol?L-1、100 nmol?L^-1 浓度下,过表达HES4使Jurkat对Ara-C的药物敏感性降低（P值分别小于0.01、0.05）; sgRNA1、sgRNA 2、sgRNA 3敲除分值分别为83、71、63,其中sgRNA1的敲除效果最佳,在Ara-C为1000 nmol?L^-1浓度下,敲除HES4促进Jurkat对Ara-C的敏感性（P < 0.05）,3条sgRNAs之间无明显区别（P > 0.05）。结论：HES4抑制T-ALL细胞系Jurkat对Ara-C的敏感性,为T-ALL化疗耐受的机制研究提供指导。     

Overexpression of extracellular sucrase (SacC) of Zymomonas mobilis in Escherichia coli

Abstract The extracellular sucrase (SacC) gene of Zymomonas mobilis was overexpressed in Escherichia coli BL21 using the T7 polymerase expression system. A low cell density induction method was designed to have maximum expression, and the conditions (IPTG concentration, ampicillin addition) were optimised to overexpress to the level of more than 60% of the total cellular protein representing SacC protein.     

来源于橄榄绿链霉菌A1的高比活木聚糖酶XYNB的高效表达及性质的比较分析

高效表达高比活木聚糖酶是进一步提高木聚糖酶发酵效价、降低其生产成本的有效途径。将橄榄绿链霉菌(Streptomyces olivaceoviridis) A1的高比活木聚糖酶成熟蛋白编码基因xynB克隆到毕赤酵母表达载体pPIC9中,转化毕赤酵母得到重组酵母,在重组酵母中木聚糖酶基因得到了高效分泌表达,且表达产物具有生物学活性。在3L发酵罐中蛋白表达量约14mg/mL, 酶活性(效价)为1200IU/mL。SDSPAGE分析表明,表达的木聚糖酶XYNBa为糖基化蛋白, 分子量为31kD, 经脱糖基化处理得到21kD 的XYNBb, 与橄榄绿链霉菌A1所产原酶XYNB大小一致。通过对XYNB、XYNBa及XYNBb酶学性质的比较发现：三者在比活性、Vmax及热稳定性方面有较大差异。该酶对不同木聚糖的酶解产物的糖份分析表明：酶解产物的主要成分为木二糖、木三糖和木四糖,占总糖含量的95%以上。     

Overexpression,one-step purification,and characterization of a type II cholesterol oxidase from a local isolate <Emphasis Type="Italic">Rhodococcus</Emphasis> sp. PTCC 1633

A 1.6 kb gene encoding a cholesterol oxidase (choR) from a local isolate, Rhodococcus sp. PTCC 1633 was cloned into pET23a and the highly expressed recombinant enzyme was purified from the cell lysate of IPTG-induced Escherichia coli BL21(DE3)pLysS with one-step absorption on cholesterol. The purified protein had a molecular mass of 55 kDa, isoelectric point at about pH 9.0 and absorption peaks at 280, 380 and 460 nm, indicating that the enzyme is a flavoprotein. The optimum pH and temperature for the recombinant enzyme were 7.0 and 50°C, respectively. Steady-state kinetic revealed that the cholesterol oxidase had a K _m of 32 μM. This study is the first report concerning expression and one-step purification of a gene encoding cholesterol oxidase from Rhodococcus spp. This study revealed that this enzyme is a type II cholesterol oxidase.     

Overexpression of E2F-1 inhibits progression of gastric cancer in vitro

E2F-1 plays a critical role in cell cycle regulation and other biological processes in cells. E2F-1 mediates apoptosis and suppresses tumorigenesis in many tissue types, but there are few data available on E2F-1 expression and its relationship to tumor kinetics in gastric cancer. To gain better insight into the involvement of E2F-1 in the biological characteristics of gastric tumors, we investigated the effect of E2F-1 overexpression on the progression of gastric carcinoma cells. A gastric cancer cell line stably overexpressing E2F-1 (MGC-803/E2F-1) was established. The influence of E2F-1 overexpression on in vitro cell growth was assessed by measuring cell survival, colony formation, and cell cycle progression. The results clearly show that overexpression of E2F-1 significantly inhibits cell growth and proliferation, blocking entry into the S-phase of the cell cycle. MGC-803/E2F-1 cells also had a higher apoptotic rate than control cells. In addition, E2F-1 reduced the motility and invasion of gastric cancer cells.     

Characterization and Functional Analysis of Voltage‐Dependent Anion Channel 1 (VDAC1) from Orange‐Spotted Grouper (Epinephelus coioides)

The voltage‐dependent anion channel (VDAC) is a highly conserved integral protein of mitochondria in different eukaryotic species. It forms a selective channel in the mitochondrial outer membrane that serves as the controlled pathway for small metabolites and ions. In this study, a VDAC gene, EcVDAC1, was isolated from orange‐spotted grouper (Epinephelus coioides). The EcVDAC1 exhibits ubiquitous expression in various tissues of orange‐spotted grouper and is upregulated in liver, gill, and spleen after stimulation with lipopolysaccharides (LPS). Subcellular localization analysis shows that the EcVDAC1 protein colocalized with the mitochondria. A caspase‐3 assay demonstrates that overexpression of the EcVDAC1 induced apoptotic cell death in fathead minnow cells. The data presented in this study provide new information regarding the relationship between LPS and the EcVDAC1 gene, suggesting that the fish VDAC1 gene may play an important role in antibacterial immune response.     

Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells

Overexpression of the ErbB2 receptor in one-third of human breast cancers contributes to the transformation of epithelial cells and predicts poor prognosis for breast cancer patients. We report that the overexpression of ErbB2 inhibits IGF-I-induced MAPK signaling. IGF-I-induced MAPK phosphorylation and MAPK kinase activity are reduced in ErbB2 overexpressing MCF-7/HER2-18 cells relative to control MCF-7/neo cells. In SKBR3/IGF-IR cells, reduction of ErbB2 by antisense methodology restores the IGF-I-induced MAPK activation. The inhibition of IGF-I-induced MAP kinase activation in ErbB2 overexpressing breast cancer cells is correlated with decreased IGF-I-induced Shc tyrosine-phosphorylation, leading to a decreased association of Grb2 with Shc and decreased Raf phosphorylation. However, IGF-I-induced tyrosine-phosphorylation of IGF-I receptor and IRS-I and AKT phosphorylation were unaffected by ErbB2 overexpression. Consistent with these results, we observed that the proportion of IGF-I-stimulated proliferation blocked by the MAPK inhibitor PD98059 fell from 82.6% in MCF-7/neo cells to 41.2% in MCF-7/HER2-18 cells. These data provide evidence for interplay between the IGF-IR and ErbB2 signaling pathways. They are consistent with the view that the IGF-IR mediated attenuation of trastuzumab-induced growth inhibition we recently described is dependent on IGF-I-induced PI3K signaling rather than IGF-I-induced MAPK signaling.